On June 25, 2015, an objection to the motion for authority to sell assets of the estates pursuant to section 363 of the Bankruptcy Code was filed in the bankruptcy case of Dendreon Corporation and its affiliates.
The filing was assigned docket number 796 and is described on the court’s official docket as follows:
Joinder of Valeant to Plan Administrator’s Objection to (I) Motion to Stay the Effectiveness of the Sale Order and the Closing of the Sale Pending Review by This Court and/or Appeal to the District Court and (II) Limited Objection to Debtor’s Plan of Objection (related document(s), , , , ) Filed by Valeant Pharmaceuticals International, Inc.. (Attachments: # (1) Certificate of Service) (Semmelman, Tyler)
Dendreon Corporation filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on November 10, 2014. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 14-12515. The bankruptcy case is currently assigned to United States Bankruptcy Judge Peter Walsh. The law firm of Skadden, Arps, Slate, Meagher & Flom LLP is acting as lead bankruptcy counsel to Dendreon Corporation in the bankruptcy case.